Hematology, Transfusion and Cell Therapy

Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression Lucia Vráblová; Hana Klamová; Ivana Skoumalová; Jana Navrátilová; Romana Janská; Jan Grohmann; Milena Holzerová; Edgar Faber;

Equity program: strategies on clinical studies as an aggregating potential Edvan de Queiroz Crusoe; Abrahão Elias Hallack Neto; Deise Ferreira Nantes; Eduardo Flavio Oliveira Ribeiro; Fernando Monteiro Correia Pinto; Jaisson Andre Pagnoncelli Bortolini; James Farley Rafael Maciel; Jose Francisco Comenalli Marques Junior; Lorena Costa Corrêa; Marcelo Eduardo Zanella Capra; Maria do Perpétuo Socorro Sampaio Carvalho; Nelcivone Soares de Melo; Rafaela Vasques de Oliveira Quintas; Thiago Xavier Carneiro; Violete Petitto Laforga; Renato Luiz Guerino Cunha;

Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia Elda Pereira Noronha; Priscilla Moniz Sodré Ferreira; Francianne Gomes Andrade; Caroline Barbieri Blunck; Ricardo Camargo; Etel Rodrigues Pereira Gimba; Maria S. Pombo-de-Oliveira; Eugênia Terra-Granado;